Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system.

Yossi Gafni1, Gadi Pelled, Yoram Zilberman

  • 1Skeletal Biotechnology Laboratory, Hebrew University-Hadassah Medical Center, Ein Kerem, P.O. Box 12272, Jerusalem 91120, Israel.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|April 20, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotype-specific muscle proteomic profiling in titinopathies.

Acta neuropathologica communications·2026
Same author

Guidelines for Comparing Circular Dichroism Spectroscopy and Molecular Dynamics Simulations for Biomolecules.

Chemphyschem : a European journal of chemical physics and physical chemistry·2026
Same author

Non-destructive pipeline for analysis of crystalline solid dispersions.

International journal of pharmaceutics·2026
Same author

Intracranial and Peripheral Inflammatory Biomarkers Predict Futile Recanalization After Endovascular Treatment.

Stroke·2026
Same author

Generation of BBSOAS patient-specific induced pluripotent stem cell lines harboring six NR2F1 pathogenic variants.

Stem cell research·2026
Same author

Mammalian mesenchymal stromal cells enhance zebrafish fin regeneration.

Cell regeneration (London, England)·2026

This study demonstrates that a dual-construct adeno-associated virus (AAV) vector delivering bone morphogenetic protein-2 (BMP-2) effectively induces bone regeneration. Doxycycline administration controlled BMP-2 expression, enabling safe and regulated bone repair in vivo.

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Regenerative Medicine

Background:

  • Adeno-associated virus (AAV) vectors are promising for gene therapy due to high transduction rates and biosafety.
  • Bone morphogenetic protein-2 (BMP-2) is a potent osteoinductive factor crucial for bone formation.
  • Controlled expression of therapeutic genes like BMP-2 is essential for safe and effective bone regeneration.

Purpose of the Study:

  • To develop and evaluate a Tet-ON regulated adeno-associated virus (AAV) vector for delivering recombinant human bone morphogenetic protein-2 (rhBMP-2).
  • To assess the efficacy of this system in inducing and controlling bone formation in vivo.

Main Methods:

  • Construction of a dual-construct recombinant AAV (rAAV) vector encoding rhBMP-2 under a tetracycline-sensitive promoter (TetON).

Related Experiment Videos

  • Administration of doxycycline (Dox) to induce rhBMP-2 expression in mice.
  • Evaluation of bone formation using micro-computed tomography (micro-CT) and osteocalcin expression analysis.

    • Main Results:

    • The rAAV-rhBMP-2 vector successfully induced bone formation in both ectopic and orthotopic mouse models when treated with Dox.
    • Mice not receiving Dox showed no significant bone formation, indicating effective regulation.
    • Osteocalcin expression confirmed osteogenic activity at the cellular level.

    Conclusions:

    • The Tet-regulated rAAV-rhBMP-2 vector system provides an effective method for controlled induction of bone regeneration.
    • This approach offers a promising strategy for therapeutic bone repair and regeneration.